Moreover, Il10-KO CD8+ TRL–treated mice exhibited increased brain expression of IL-6, CCL1, and CCL2 after stroke compared with WT CD8+ TRL–treated mice (Supplemental Figure 5G). The gene discussed is CCL1; the disease is stroke disorder.